Last reviewed · How we verify
NCT03826303
The Impact of Vaping Ethanol in the Evaluation of Impairment
NA trial testing E-cigarette liquid with ethanol, 1 puff in Electronic Cigarette Use in 17 participants. Completed in 8 April 2022.
8 April 2022
Quick facts
| Lead sponsor | Virginia Commonwealth University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 17 |
| Start date | 2 April 2021 |
| Primary completion | 8 April 2022 |
| Estimated completion | 8 April 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- E-cigarette liquid with ethanol, 1 puff
- E-cigarette liquid without ethanol, 1 puff
- E-cigarette liquid with ethanol, 10 puffs
- E-cigarette liquid without ethanol, 10 puffs
Conditions studied
- Electronic Cigarette Use — all drugs for Electronic Cigarette Use →
Sponsor
Virginia Commonwealth University
Who can join
Adults 21 to 65, any sex, with Electronic Cigarette Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research study is to find out about ethanol-containing e-cigarettes impact ethanol breath tests, field sobriety tests, or other tests of sobriety. Ethanol is a common part of e-cigarette liquids.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03826303
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Electronic Cigarette Use
Currently open trials in the same condition.
- NCT06609109 — Effect of Cannabis on E-Cigarette Use Behavior · Phase 1 · recruiting
- NCT06610838 — Effects of E-cigarette Use on Health · recruiting
- NCT04907136 — Developing and Testing Health Warning Labels on the ENDS Device · NA · recruiting
- NCT06142877 — Effects of Social Media Use on Young Adults' E-Cigarette Use · NA · recruiting
- NCT05338801 — Effect of Menthol on ENDS Users' Addiction and Exposure · NA · recruiting
Other Virginia Commonwealth University trials
Trials by the same sponsor.
- NCT05936931 — Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening · NA · not yet recruiting
- NCT07365839 — Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · Phase 1 · not yet recruiting
- NCT07178158 — Enhancing Addiction Treatment Through Psychoeducation · NA · not yet recruiting
- NCT07531316 — Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers · Phase 1 · not yet recruiting
- NCT07426913 — Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03826303 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Virginia Commonwealth University
- Last refreshed: 19 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03826303.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing